| Multidrug‐resistant, extensively drug‐resistant and pandrug‐resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance AP Magiorakos, A Srinivasan, RB Carey, Y Carmeli, ME Falagas, ... Clinical microbiology and infection 18 (3), 268-281, 2012 | 5058 | 2012 |
| Comparison of Mortality Associated with Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Meta-analysis SE Cosgrove, G Sakoulas, EN Perencevich, MJ Schwaber, AW Karchmer, ... Clinical infectious diseases 36 (1), 53-59, 2003 | 2193 | 2003 |
| The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges SE Cosgrove, Y Qi, KS Kaye, S Harbarth, AW Karchmer, Y Carmeli Infection Control & Hospital Epidemiology 26 (2), 166-174, 2005 | 1062 | 2005 |
| Adverse Clinical and Economic Outcomes Attributable to Methicillin Resistance among Patients with Staphylococcus aureus Surgical Site Infection JJ Engemann, Y Carmeli, SE Cosgrove, VG Fowler, MZ Bronstein, ... Clinical infectious diseases 36 (5), 592-598, 2003 | 1043 | 2003 |
| Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact V Aloush, S Navon-Venezia, Y Seigman-Igra, S Cabili, Y Carmeli Antimicrobial agents and chemotherapy 50 (1), 43-48, 2006 | 797 | 2006 |
| Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe R Cantón, M Akóva, Y Carmeli, CG Giske, Y Glupczynski, M Gniadkowski, ... Clinical Microbiology and Infection 18 (5), 413-431, 2012 | 751 | 2012 |
| Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents Y Carmeli, N Troillet, GM Eliopoulos, MH Samore Antimicrobial agents and chemotherapy 43 (6), 1379-1382, 1999 | 713 | 1999 |
| Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance S Harbarth, MH Samore, D Lichtenberg, Y Carmeli Circulation 101 (25), 2916-2921, 2000 | 653 | 2000 |
| Clinical and economic impact of common multidrug-resistant gram-negative bacilli CG Giske, DL Monnet, O Cars, Y Carmeli Antimicrobial agents and chemotherapy 52 (3), 813-821, 2008 | 652 | 2008 |
| Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis MJ Schwaber, Y Carmeli Journal of Antimicrobial Chemotherapy 60 (5), 913-920, 2007 | 631 | 2007 |
| The impact of antimicrobial resistance on health and economic outcomes GM Eliopoulos, SE Cosgrove, Y Carmeli Clinical infectious diseases 36 (11), 1433-1437, 2003 | 618 | 2003 |
| Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258 B Kitchel, JK Rasheed, JB Patel, A Srinivasan, S Navon-Venezia, ... Antimicrobial agents and chemotherapy 53 (8), 3365-3370, 2009 | 512 | 2009 |
| A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients R Ben-Ami, J Rodríguez-Baño, H Arslan, JDD Pitout, C Quentin, ES Calbo, ... Clinical Infectious Diseases 49 (5), 682-690, 2009 | 500 | 2009 |
| Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality MJ Schwaber, S Klarfeld-Lidji, S Navon-Venezia, D Schwartz, A Leavitt, ... Antimicrobial agents and chemotherapy 52 (3), 1028-1033, 2008 | 498 | 2008 |
| Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae MJ Schwaber, S Navon-Venezia, KS Kaye, R Ben-Ami, D Schwartz, ... Antimicrobial agents and chemotherapy 50 (4), 1257-1262, 2006 | 468 | 2006 |
| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet Infectious Diseases 18 (3), 318-327, 2018 | 463 | 2018 |
| Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa Y Carmeli, N Troillet, AW Karchmer, MH Samore Archives of Internal Medicine 159 (10), 1127-1132, 1999 | 423 | 1999 |
| Influx of Extended-Spectrum β-Lactamase—Producing Enterobacteriaceae into the Hospital R Ben-Ami, MJ Schwaber, S Navon-Venezia, D Schwartz, M Giladi, ... Clinical Infectious Diseases 42 (7), 925-934, 2006 | 400 | 2006 |
| Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients SG Weber, HS Gold, DC Hooper, AW Karchmer, Y Carmeli Emerging infectious diseases 9 (11), 1415, 2003 | 389 | 2003 |
| Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention MJ Schwaber, B Lev, A Israeli, E Solter, G Smollan, B Rubinovitch, I Shalit, ... Clinical infectious diseases 52 (7), 848-855, 2011 | 375 | 2011 |
